{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:09:29Z","timestamp":1768712969226,"version":"3.49.0"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science & Technology, Government of India","doi-asserted-by":"publisher","award":["SR\/WOS-A\/LS-1164\/2014"],"award-info":[{"award-number":["SR\/WOS-A\/LS-1164\/2014"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2019,9,3]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Plant sterols have proven a potent anti-proliferative and apoptosis inducing agent against several carcinomas including breast and prostate cancers. Jab1 has been reported to be involved in the progression of numerous carcinomas. However, antiproliferative effects of sterols against Jab1 in gall bladder cancer have not been explored yet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>In the current study, we elucidated the mechanism of action of stigmasterol regarding apoptosis induction mediated via downregulation of Jab1 protein in human gall bladder cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>In our study, we performed MTT and Trypan blue assay to assess the effect of stigmasterol on cell proliferation. In addition, RT-PCR and western blotting were performed to identify the effect of stigmasterol on Jab1 and p27 expression in human gall bladder cancer cells. We further performed cell cycle, Caspase-3, Hoechst and FITC-Annexin V analysis, to confirm the apoptosis induction in stigmasterol treated human gall bladder cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Our results clearly indicated that stigmasterol has up-regulated the p27 expression and down-regulated Jab1 gene. These modulations of genes might occur via mitochondrial apoptosis signaling pathway. Caspase-3 gets activated with the apoptotic induction. Increase in apoptotic cells and DNA were confirmed through annexin V staining, Hoechst staining, and cell cycle analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Thus, these results strongly suggest that stigmasterol has the potential to be considered as an anticancerous therapeutic agent against Jab1 in gall bladder cancer.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871530319666190206124120","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T07:53:55Z","timestamp":1549526035000},"page":"826-837","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Elucidation of the Chemopreventive Role of Stigmasterol Against Jab1 in Gall Bladder Carcinoma"],"prefix":"10.2174","volume":"19","author":[{"given":"Pratibha","family":"Pandey","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzma","family":"Sayyed","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafia","family":"Shekh","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumudesh","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.K.","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0271-5317(00)00288-8","volume":"21","author":"Lopaczynski W.","year":"2001","unstructured":"Lopaczynski W.; Zeisel S.H.; Antioxidants, programmed cell death, and cancer. Nutr Res 2001,21(1-2),295-307","journal-title":"Nutr Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.canlet.2010.07.004","volume":"332","author":"von Schwarzenberg K.","year":"2013","unstructured":"von Schwarzenberg K.; Vollmar A.M.; Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy. Cancer Lett 2013,332(2),295-303","journal-title":"Cancer Lett"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"G629","DOI":"10.1152\/ajpgi.00201.2015","volume":"310","author":"Khoogar R.","year":"2016","unstructured":"Khoogar R.; Kim B.C.; Morris J.; Wargovich M.J.; Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: A focus on gastrointestinal cancer. Am J Physiol Gastrointest Liver Physiol 2016,310(9),G629-G644","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"Cragg G.M.","year":"2013","unstructured":"Cragg G.M.; Newman D.J.; Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013,1830(6),3670-3695","journal-title":"Biochim Biophys Acta"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.3390\/molecules190811679","volume":"19","author":"Chinembiri T.N.","year":"2014","unstructured":"Chinembiri T.N.; du Plessis L.H.; Gerber M.; Hamman J.H.; du Plessis J.; Review of natural compounds for potential skin cancer treatment. Molecules 2014,19(8),11679-11721","journal-title":"Molecules"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/1389450117666160112113930","volume":"18","author":"Colomer R.","year":"2017","unstructured":"Colomer R.; Sarrats A.; Lupu R.; Puig T.; Natural polyphenols and their synthetic analogs as emerging anticancer agents. Curr Drug Targets 2017,18(2),147-159","journal-title":"Curr Drug Targets"},{"key":"ref=7","author":"Blowman K.","year":"2018","unstructured":"Blowman K.; Magalh\u00e3es M.; Lemos M.F.L.; Cabral C.; Pires I.M.; Anticancer properties of essential oils and other natural products. Evid Based Complement Alternat Med 201831493622018","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/ajcn\/40.4.927","volume":"40","author":"Nair P.P.","year":"1984","unstructured":"Nair P.P.; Turjman N.; Kessie G.; Calkins B.; Goodman G.T.; Davidovitz H.; Nimmagadda G.; Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Dietary cholesterol, \u03b2-sitosterol, and stigmasterol. Am J Clin Nutr 1984,40(4)(Suppl.),927-930","journal-title":"Am J Clin Nutr"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopha.2017.01.068","volume":"88","author":"Shahzad N.","year":"2017","unstructured":"Shahzad N.; Khan W.; Md S.; Ali A.; Saluja S.S.; Sharma S.; Al-Allaf F.A.; Abduljaleel Z.; Ibrahim I.A.A.; Abdel-Wahab A.F.; Afify M.A.; Al-Ghamdi S.S.; Phytosterols as a natural anticancer agent: Current status and future perspective. Biomed Pharmacother 2017,88,786-794","journal-title":"Biomed Pharmacother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/01635589809514709","volume":"32","author":"von Holtz R.L.","year":"1998","unstructured":"von Holtz R.L.; Fink C.S.; Awad A.B.; \u03b2-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer 1998,32(1),8-12","journal-title":"Nutr Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jnutbio.2012.01.007","volume":"24","author":"Llaverias G.","year":"2013","unstructured":"Llaverias G.; Escol\u00e0-Gil J.C.; Lerma E.; Julve J.; Pons C.; Cabr\u00e9 A.; Cof\u00e1n M.; Ros E.; S\u00e1nchez-Quesada J.L.; Blanco-Vaca F.; Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer. J Nutr Biochem 2013,24(1),39-48","journal-title":"J Nutr Biochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"10793","DOI":"10.1021\/jf1023017","volume":"58","author":"O\u2019Callaghan Y.C.","year":"2010","unstructured":"O\u2019Callaghan Y.C.; Foley D.A.; O\u2019Connell N.M.; McCarthy F.O.; Maguire A.R.; O\u2019Brien N.M.; Cytotoxic and apoptotic effects of the oxidized derivatives of stigmasterol in the U937 human monocytic cell line. J Agric Food Chem 2010,58(19),10793-10798","journal-title":"J Agric Food Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"Otto T.","year":"2017","unstructured":"Otto T.; Sicinski P.; Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 2017,17(2),93-115","journal-title":"Nat Rev Cancer"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"Malumbres M.","year":"2009","unstructured":"Malumbres M.; Barbacid M.; Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009,9(3),153-166","journal-title":"Nat Rev Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-cancerbio-040716-075628","volume":"1","author":"Sherr C.J.","year":"2017","unstructured":"Sherr C.J.; Bartek J.; Cell cycle\u2013targeted cancer therapies. Annual Review of Cancer Biology 2017,1,41-57","journal-title":"Annual Review of Cancer Biology"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1098\/rsfs.2013.0075","volume":"4","author":"G\u00e9rard C.","year":"2014","unstructured":"G\u00e9rard C.; Goldbeter A.; The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition. Interface Focus 2014,4(3)","journal-title":"Interface Focus"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.cr.7290031","volume":"10","author":"Donjerkovic D.","year":"2000","unstructured":"Donjerkovic D.; Scott D.W.; Regulation of the G1 phase of the mammalian cell cycle. Cell Res 2000,10(1),1-16","journal-title":"Cell Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"25","author":"Giacinti C.","year":"2006","unstructured":"Giacinti C.; Giordano A.; RB and cell cycle progression. Oncogene 2006,25(38),5220-5227","journal-title":"Oncogene"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.26452\/ijrps.v9i1.1176","volume":"9","author":"Pandey P.","year":"2018","unstructured":"Pandey P.; Sayyed U.; Tiwari R.; Pathak N.; Siddiqui M.H.; Bajpai P.; Anticancer and apoptosis-inducing effects of curcumin against gall bladder carcinoma. Int J Pharm Sci Res 2018,9(1),68-77","journal-title":"Int J Pharm Sci Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/01635581.2017.1359321","volume":"69","author":"Khan F.","year":"2017","unstructured":"Khan F.; Khan I.; Farooqui A.; Ansari I.A.; Carvacrol induces reactive oxygen species (ros)-mediated apoptosis along with cell cycle arrest at g0\/g1 in human prostate cancer cells. Nutr Cancer 2017,69(7),1075-1087","journal-title":"Nutr Cancer"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biopha.2017.10.147","volume":"97","author":"Farooqui A.","year":"2018","unstructured":"Farooqui A.; Khan F.; Khan I.; Ansari I.A.; Glycyrrhizin induces reactive oxygen species-dependent apoptosis and cell cycle arrest at G\/G in HPV18 human cervical cancer HeLa cell line. Biomed Pharmacother 2018,97,752-764","journal-title":"Biomed Pharmacother"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/34112","volume":"391","author":"Enari M.","year":"1998","unstructured":"Enari M.; Sakahira H.; Yokoyama H.; Okawa K.; Iwamatsu A.; Nagata S.; A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998,391(6662),43-50","journal-title":"Nature"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2174\/138945012802009044","volume":"13","author":"Martin-Cordero C.","year":"2012","unstructured":"Martin-Cordero C.; Leon-Gonzalez A.J.; Calderon-Montano J.M.; Burgos-Moron E.; Lopez-Lazaro M.; Pro-oxidant natural products as anticancer agents. Curr Drug Targets 2012,13(8),1006-1028","journal-title":"Curr Drug Targets"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/1078-0432.CCR-06-2082","volume":"13","author":"Fruehauf J.P.","year":"2007","unstructured":"Fruehauf J.P.; Meyskens F.L.; Jr Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007,13(3),789-794","journal-title":"Clin Cancer Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"Trachootham D.","year":"2009","unstructured":"Trachootham D.; Alexandre J.; Huang P.; Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat Rev Drug Discov 2009,8(7),579-591","journal-title":"Nat Rev Drug Discov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0006-3495(99)77214-0","volume":"76","author":"Scaduto R.C.","year":"1999","unstructured":"Scaduto R.C.; Grotyohann L.W.; ScadutoJr. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 1999,76(1 Pt 1),469-477","journal-title":"Biophys J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"27643","DOI":"10.1074\/jbc.M603536200","volume":"281","author":"Schieke S.M.","year":"2006","unstructured":"Schieke S.M.; Phillips D.; McCoy J.P.; Aponte A.M.; Shen R.F.; Balaban R.S.; Finkel T.; The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006,281(37),27643-27652","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/0005-2728(86)90112-X","volume":"850","author":"Emaus R.K.","year":"1986","unstructured":"Emaus R.K.; Grunwald R.; Lemasters J.J.; Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta 1986,850(3),436-448","journal-title":"Biochim Biophys Acta"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1073\/pnas.93.13.6458","volume":"93","author":"Polla B.S.","year":"1996","unstructured":"Polla B.S.; Kantengwa S.; Fran\u00e7ois D.; Salvioli S.; Franceschi C.; Marsac C.; Cossarizza A.; Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA 1996,93(13),6458-6463","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.molcel.2015.09.003","volume":"59","author":"Duan S.","year":"2015","unstructured":"Duan S.; Pagano M.; SPOP mutations or ERG rearrangements result in enhanced levels of ERG to promote cell invasion in prostate cancer. Mol Cell 2015,59(6),883-884","journal-title":"Mol Cell"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T23:30:01Z","timestamp":1606433401000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169656\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666190206124120","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}